SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-010338
Filing Date
2023-03-28
Accepted
2023-03-28 16:53:37
Documents
76
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K stsa-20221231.htm   iXBRL 10-K 3382275
2 EX-4.6 stsa-ex4_6.htm EX-4 58501
3 EX-23.1 stsa-ex23_1.htm EX-23 2957
4 EX-31.1 stsa-ex31_1.htm EX-31 21029
5 EX-31.2 stsa-ex31_2.htm EX-31 20873
6 EX-32.1 stsa-ex32_1.htm EX-32 12146
7 EX-32.2 stsa-ex32_2.htm EX-32 12144
8 GRAPHIC img21124571_0.jpg GRAPHIC 11911
9 GRAPHIC img21124571_1.jpg GRAPHIC 29062
10 GRAPHIC img21124571_2.jpg GRAPHIC 55030
  Complete submission text file 0000950170-23-010338.txt   11566644

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stsa-20221231_cal.xml EX-101.CAL 56269
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stsa-20221231_pre.xml EX-101.PRE 369456
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stsa-20221231_lab.xml EX-101.LAB 498716
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stsa-20221231_def.xml EX-101.DEF 211923
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stsa-20221231.xsd EX-101.SCH 57671
70 EXTRACTED XBRL INSTANCE DOCUMENT stsa-20221231_htm.xml XML 2173242
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39041 | Film No.: 23770301
SIC: 2834 Pharmaceutical Preparations